There have been promising advances in the use of pharmacologic agents for the treatment of cocaine dependence. While it is apparent that medications may be useful in the treatment of cocaine dependence, most studies indicate that medications work in some, but not all, cocaine abusers. With the variety of pharmacologic agents currently under investigation and the known heterogeneity of the cocaine-abusing population, a mechanism for sub-typing cocaine abusers for the purpose of matching to the most appropriate pharmacologic treatment would be of value. As many cocaine abusers are reported to have mood disorders, one logical way to subtype patients is on the presence or absence of a mood disorder.
The specific aims of the current proposal are: 1) to use state-of-the-art psychiatric instruments to diagnose co-existing psychiatric disorders and monitor psychiatric symptoms in patients presenting for cocaine treatment, and 2) to conduct a 12-week, placebo-controlled trial comparing the efficacy of carbamazepine in the treatment of cocaine-dependence in patients with and without affective disorders. More specifically, the protocol proposes a double-blind, placebo-controlled clinical trial of carbamazepine in patients with and without affective disorders over a 12-week treatment period with a 24-week follow-up assessment. The unique features of the protocol are that: 1) it will provide placebo-controlled data concerning the efficacy of carbamazepine and the serum level/clinical efficacy of carbamazepine in the treatment of cocaine dependence; 2) it is designed to stratify subjects with lifetime history of affective illness between the carbamazepine and placebo groups so a potential differential effect of medications on these two groups can be investigated; 3) all patients will be drug free at the time of initiation of drug treatment; 4) it includes a riboflavin marker in the both placebo and drug groups to permit evaluation of patient compliance; and 5) it uses state-of-the-art assessment instruments to evaluate the treatment impact on, not only cocaine use and craving, but outcome variables related to several additional dimensions. As the cocaine abuse problem in this country has grown to such large proportions, it is becoming increasingly important to develop more efficient and cost effective methods of substance abuse treatment. Matching patients to treatment on the basis of psychiatric co-morbidity is one promising avenue for designing treatments for specific populations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29DA007761-01
Application #
2120256
Study Section
Special Emphasis Panel (SRCD (45))
Project Start
1992-09-29
Project End
1997-09-28
Budget Start
1992-09-29
Budget End
1993-09-29
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Psychiatry
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Coffey, Scott F; Schumacher, Julie A; Brimo, Marcella L et al. (2005) Exposure therapy for substance abusers with PTSD: translating research to practice. Behav Modif 29:10-38
Brady, Kathleen T; Sonne, Susan C; Malcolm, Robert J et al. (2002) Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol 10:276-85
Back, S E; Dansky, B S; Carroll, K M et al. (2001) Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: description of procedures. J Subst Abuse Treat 21:35-45
Brady, K T; Dansky, B S; Back, S E et al. (2001) Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings. J Subst Abuse Treat 21:47-54
Back, S; Dansky, B S; Coffey, S F et al. (2000) Cocaine dependence with and without post-traumatic stress disorder: a comparison of substance use, trauma history and psychiatric comorbidity. Am J Addict 9:51-62
Dansky, B S; Byrne, C A; Brady, K T (1999) Intimate violence and post-traumatic stress disorder among individuals with cocaine dependence. Am J Drug Alcohol Abuse 25:257-68
Dansky, B S; Brady, K T; Saladin, M E (1998) Untreated symptoms of PTSD among cocaine-dependent individuals. Changes over time. J Subst Abuse Treat 15:499-504
Saladin, M E; Brady, K T; Dansky, B S et al. (1995) Understanding comorbidity between PTSD and substance use disorders: two preliminary investigations. Addict Behav 20:643-55